CN112795669B - Yersinia enterocolitica standard strain containing specific molecular target and detection and application thereof - Google Patents
Yersinia enterocolitica standard strain containing specific molecular target and detection and application thereof Download PDFInfo
- Publication number
- CN112795669B CN112795669B CN202011615514.XA CN202011615514A CN112795669B CN 112795669 B CN112795669 B CN 112795669B CN 202011615514 A CN202011615514 A CN 202011615514A CN 112795669 B CN112795669 B CN 112795669B
- Authority
- CN
- China
- Prior art keywords
- seq
- yersinia enterocolitica
- strain
- molecular target
- enterocolitica
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000607447 Yersinia enterocolitica Species 0.000 title claims abstract description 90
- 229940098232 yersinia enterocolitica Drugs 0.000 title claims abstract description 85
- 238000001514 detection method Methods 0.000 title claims abstract description 18
- 238000011144 upstream manufacturing Methods 0.000 claims description 23
- 241000607734 Yersinia <bacteria> Species 0.000 claims description 18
- 239000003153 chemical reaction reagent Substances 0.000 claims description 12
- 238000004321 preservation Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 abstract description 21
- 125000003729 nucleotide group Chemical group 0.000 abstract description 21
- 238000004108 freeze drying Methods 0.000 abstract description 17
- 239000003223 protective agent Substances 0.000 abstract description 15
- 238000003908 quality control method Methods 0.000 abstract description 7
- 238000012408 PCR amplification Methods 0.000 abstract description 6
- 230000004083 survival effect Effects 0.000 abstract description 6
- 239000001963 growth medium Substances 0.000 abstract description 5
- 238000002474 experimental method Methods 0.000 abstract description 4
- 230000008859 change Effects 0.000 abstract description 2
- 239000013074 reference sample Substances 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 36
- 241000894006 Bacteria Species 0.000 description 23
- 230000015572 biosynthetic process Effects 0.000 description 22
- 238000003786 synthesis reaction Methods 0.000 description 22
- 108090000623 proteins and genes Proteins 0.000 description 20
- 230000003321 amplification Effects 0.000 description 14
- 238000003199 nucleic acid amplification method Methods 0.000 description 14
- 230000001018 virulence Effects 0.000 description 11
- 229960000723 ampicillin Drugs 0.000 description 10
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 10
- 229960000603 cefalotin Drugs 0.000 description 10
- XIURVHNZVLADCM-IUODEOHRSA-N cefalotin Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CC1=CC=CS1 XIURVHNZVLADCM-IUODEOHRSA-N 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 239000003242 anti bacterial agent Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 229960005404 sulfamethoxazole Drugs 0.000 description 8
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 8
- 230000004520 agglutination Effects 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 229940088710 antibiotic agent Drugs 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 238000012795 verification Methods 0.000 description 7
- 206010059866 Drug resistance Diseases 0.000 description 6
- 229930182555 Penicillin Natural products 0.000 description 6
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 6
- 229940049954 penicillin Drugs 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 5
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229960004261 cefotaxime Drugs 0.000 description 4
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 101150036586 FES gene Proteins 0.000 description 3
- 108010024636 Glutathione Proteins 0.000 description 3
- 101100125056 Yersinia enterocolitica ystB gene Proteins 0.000 description 3
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 208000010227 enterocolitis Diseases 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 229960002901 sodium glycerophosphate Drugs 0.000 description 3
- REULQIKBNNDNDX-UHFFFAOYSA-M sodium;2,3-dihydroxypropyl hydrogen phosphate Chemical compound [Na+].OCC(O)COP(O)([O-])=O REULQIKBNNDNDX-UHFFFAOYSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 101150089095 ymoA gene Proteins 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 101100066562 Escherichia coli (strain K12) fepA gene Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 238000003794 Gram staining Methods 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 108010046334 Urease Proteins 0.000 description 2
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 2
- NMVPEQXCMGEDNH-TZVUEUGBSA-N ceftazidime pentahydrate Chemical compound O.O.O.O.O.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 NMVPEQXCMGEDNH-TZVUEUGBSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000011331 genomic analysis Methods 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 238000012543 microbiological analysis Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- -1 30. mu.g) Chemical compound 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 206010003267 Arthritis reactive Diseases 0.000 description 1
- 101100394741 Bordetella bronchiseptica (strain ATCC BAA-588 / NCTC 13252 / RB50) rfaE gene Proteins 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 101100173534 Escherichia coli (strain K12) fepD gene Proteins 0.000 description 1
- 241001360526 Escherichia coli ATCC 25922 Species 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- WKDDRNSBRWANNC-UHFFFAOYSA-N Thienamycin Natural products C1C(SCCN)=C(C(O)=O)N2C(=O)C(C(O)C)C21 WKDDRNSBRWANNC-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 101100025385 Yersinia enterocolitica myfA gene Proteins 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229960000484 ceftazidime Drugs 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960003324 clavulanic acid Drugs 0.000 description 1
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 101150098460 hldE gene Proteins 0.000 description 1
- 238000013095 identification testing Methods 0.000 description 1
- 229960002182 imipenem Drugs 0.000 description 1
- ZSKVGTPCRGIANV-ZXFLCMHBSA-N imipenem Chemical compound C1C(SCC\N=C\N)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 ZSKVGTPCRGIANV-ZXFLCMHBSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 208000002574 reactive arthritis Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229960004659 ticarcillin Drugs 0.000 description 1
- OHKOGUYZJXTSFX-KZFFXBSXSA-N ticarcillin Chemical compound C=1([C@@H](C(O)=O)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)C=CSC=1 OHKOGUYZJXTSFX-KZFFXBSXSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 206010048282 zoonosis Diseases 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
Abstract
The invention provides three standard strains which can be used as a reference for experiments related to the Yersinia enterocolitica (Yersinia enterocolitica), wherein the standard strains have typical colonial morphology and physiological and biochemical characteristics of the Yersinia enterocolitica, can be used for checking the accuracy of a selective culture medium of the Yersinia enterocolitica, and can be used as a reference sample in the detection of common physiological and biochemical phenotypes and molecular characteristics of the Yersinia enterocolitica; the standard strain contains a corresponding specific molecular target (such as a nucleotide sequence shown in SEQ ID NO: 1-11), and also provides a specific PCR amplification primer containing the specificity of the molecular target. The invention also provides a freeze-drying protective agent for the yersinia enterocolitica, and the freeze-drying survival rate of the protective agent can reach more than 85 percent; the strain can be preserved at the temperature of 20 ℃ below zero to ensure that the magnitude of the strain does not change for more than one year, so the strain can be used for storing the quality control strain for a long time.
Description
Technical Field
The invention belongs to the technical field of microbiological examination, and particularly relates to a standard strain of yersinia enterocolitica; physiological, biochemical and molecular characteristics of the strain; corresponding molecular target and PCR amplification primer and a method for preserving yersinia enterocolitica.
Background
Yersinia enterocolitica (y.enterocolitica), a gram-negative zoonosis pathogen, is widely distributed in nature and is a major cause of yersinia disease. Since it can grow in a low temperature environment (0-4 ℃), frozen and refrigerated foods have recently become a new important source of infection of the disease. The main symptoms of yersinia disease are gastroenteritis, pseudoappendicitis, diarrhea and the like, and a small part of patients can suffer from chronic diseases such as reactive arthritis and the like due to infection. The monitoring data of the European Union food safety agency 2013 and 2017 show that the number of the affected people of the yersinia disease is third in the livestock-related diseases within the range of the European Union, and the number of the affected people is in an increasing trend along with the improvement of a monitoring and reporting system of the European Union member states. Yersinia enterocolitica now found can be divided into six groups according to biotype: 1A, 1B and 2-5. Of these, the 1A biotype strain has been considered to be a nonpathogenic strain in the past because it does not contain the important virulence plasmid pYV, but with the progress of research, Yersinia enterocolitica of the 1A biotype has been isolated in more and more cases of Yersinia disease, and thus Yersinia enterocolitica of the 1A biotype is considered to have a potential pathogenic potential in mammals. At present, China has defects in monitoring yersinia disease, and the pollution of yersinia enterocolitica in food temporarily lacks detailed information. Therefore, the establishment of the standard bacterial strain of the yersinia enterocolitica is of great significance for perfecting the monitoring, prevention and control of yersinia disease in China.
At present, the standard strains of yersinia enterocolitica are mainly derived from American Type Culture Collection (ATCC), China center for medical Culture of Microorganisms (CMCC), and the like. Most of the standard strains are from foreign clinical separation, and the pollution and spreading condition of the strains in food cannot be well reflected. Meanwhile, the characters of the main epidemic strains in foreign countries cannot be taken as representatives of the characters of the main epidemic strains in China due to different main epidemic strain types of yersinia enterocolitica in food in different countries and regions.
Disclosure of Invention
In order to solve the technical problems, the invention provides 3 food isolated strains of yersinia enterocolitica from China, which have typical physiological and biochemical characteristics of the yersinia enterocolitica and can better reflect the genetic background of the yersinia enterocolitica in China. Yersinia enterocolitica strain C009 is a frozen duck wing sample isolated from the carinitum region of guangzhou, china with a biotype of 1A and serotypes of O:5, the preservation number is: GDMCC60852, classification name: yersinia enterocolitica; yersinia enterocolitica strain Y802 was isolated from minced meat samples of shanghai city, china, and had a biotype of 1A and a serotype of O: and 8, the preservation number is: GDMCC60853, classification name: yersinia enterocolitica; yersinia enterocolitica strain C1702 was isolated from a beef sample from the first city of the guangdong province with a biotype of 1A, unknown serotype, and a deposit number of: GDMCC60855, classification name: yersinia enterocolitica. The yersinia enterocolitica strains C009, Y802, and C1702 obtained by the above isolation are all deposited in the Guangdong province collection of microorganisms at the addresses: the preservation date of the fifth building of the experimental building of the microbiological institute of 100 province in the first furious Zhonglu city of China: the preservation date is 2019, 10 months and 27 days.
The technical scheme adopted by the invention is as follows:
the invention provides three standard strains of yersinia enterocolitica (y. enterocolitica), which are characterized by being (a), (b) or (c):
(a) the strain C009 contains at least one nucleotide sequence shown as SEQ ID NO. 1-5;
(b) the strain Y802 contains at least one nucleotide sequence shown as SEQ ID NO. 6-10;
(c) strain C1702, containing the nucleotide sequence shown in SEQ ID NO. 11.
Preferably, said strain C009 further comprises the following virulence genes: inv, ystB, ymoA, hrep, sat, fepA, fes, fepD and myfA; and resistance to the following antibiotics: ampicillin, cephalothin and sulfamethoxazole.
Preferably, said strain Y802 also comprises the following virulence genes: ystB, ymoA, fes, sat, inv, hrep and fepA; and resistance to the following antibiotics: ampicillin, cephalothin and cefotaxime.
Preferably, said strain C1702 further comprises the following virulence genes: ystB, ymoA, fes, sat, inv, hrep and tccC; and resistance to the following antibiotics: ampicillin, cephalothin and sulfamethoxazole.
Preferably, the strain C009 has the deposit number: GDMCC 60852; the preservation number of the strain Y802 is as follows: GDMCC 60853; the deposit number of the strain C1702 is GDMCC 60855.
The invention also provides application of the yersinia enterocolitica in researching the antibiotic resistance of the yersinia enterocolitica. Preferably, the antibiotic resistance of strain-1 is resistance against ampicillin, cephalothin or sulfamethoxazole; the antibiotic drug resistance aimed by the strain-2 is the drug resistance of ampicillin, cephalothin or cefotaxime; the antibiotic drug resistance of the strain-3 is the drug resistance of ampicillin, cephalothin or sulfamethoxazole.
The invention also provides application of the yersinia enterocolitica in improving the accuracy of the yersinia enterocolitica chromogenic plate.
The invention also provides a freeze-drying protective agent for preparing quantitative yersinia enterocolitica, which comprises the following components in parts by weight: 1-3 parts of sodium glycerophosphate, 6-12 parts of skimmed milk powder, 0.1-4 parts of polyvinylpyrrolidone, 0.1-2 parts of reducing glutathione and 0.2-2 parts of L-cysteine hydrochloride.
Preferably, the lyoprotectant comprises the following components in parts by weight: 2 parts of sodium glycerophosphate, 8 parts of skim milk powder, 0.5 part of polyvinylpyrrolidone, 0.5 part of reducing glutathione and 2 parts of L-cysteine hydrochloride.
The invention also provides a specific molecular target for detecting yersinia enterocolitica, which is characterized in that the molecular target is:
(a) 1-11 of any one of the nucleotide sequences shown in SEQ ID NO; or,
(b) the nucleotide sequence in (a) is subjected to substitution, deletion or addition of one or more nucleotides, and has more than 90% homology with the nucleotides in (a). The specific molecular target of the invention is obtained by comparing the newly obtained yersinia enterocolitica through pan-genome analysis, and the yersinia enterocolitica can be specifically detected, and has stronger specificity.
The invention provides a primer for detecting the specific molecular target as claimed in claim 1, which is characterized in that a PCR primer for amplifying the nucleotide sequence shown as SEQ ID NO. 1 comprises: an upstream primer shown as SEQ ID NO. 12 and a downstream primer shown as SEQ ID NO. 13; the PCR primer for the nucleotide sequence amplification shown as SEQ ID NO. 2 comprises: an upstream primer shown as SEQ ID NO. 14 and a downstream primer shown as SEQ ID NO. 15; the PCR primers for the amplification of the nucleotide sequence shown as SEQ ID NO. 3 comprise an upstream primer shown as SEQ ID NO. 16 and a downstream primer shown as SEQ ID NO. 14; the PCR primers for the amplification of the nucleotide sequence shown as SEQ ID NO. 4 comprise an upstream primer shown as SEQ ID NO. 18 and a downstream primer shown as SEQ ID NO. 19; the PCR primer for the amplification of the nucleotide sequence shown as SEQ ID NO. 5 comprises an upstream primer shown as SEQ ID NO. 20 and a downstream primer shown as SEQ ID NO. 21; the PCR primers for the amplification of the nucleotide sequence shown as SEQ ID NO. 6 comprise an upstream primer shown as SEQ ID NO. 22 and a downstream primer shown as SEQ ID NO. 23; the PCR primers for the amplification of the nucleotide sequence shown as SEQ ID NO. 7 comprise an upstream primer shown as SEQ ID NO. 24 and a downstream primer shown as SEQ ID NO. 25; the PCR primer for the amplification of the nucleotide sequence shown as SEQ ID NO. 8 comprises an upstream primer shown as SEQ ID NO. 26 and a downstream primer shown as SEQ ID NO. 27; the PCR primers for the amplification of the nucleotide sequence shown as SEQ ID NO. 9 comprise an upstream primer shown as SEQ ID NO. 28 and a downstream primer shown as SEQ ID NO. 29; the PCR primers for the amplification of the nucleotide sequence shown as SEQ ID NO. 10 comprise an upstream primer shown as SEQ ID NO. 30 and a downstream primer shown as SEQ ID NO. 31; the PCR primers for the amplification of the nucleotide sequence shown in SEQ ID NO. 11 include an upstream primer shown in SEQ ID NO. 32 and a downstream primer shown in SEQ ID NO. 33.
The invention has the beneficial effects that: the yersinia enterocolitica GDMCC60852, GDMCC60853 and GDMCC60855 have typical colony morphology and physiological and biochemical characteristics of the yersinia enterocolitica and can be used for testing the accuracy of the selective medium for the yersinia enterocolitica. The biological types and serotypes of the strains are clear, the carried virulence genes and the drug resistance spectrum are clear, and compared with the currently commonly used yersinia enterocolitica standard strains, the strains are the only strains which can accurately reflect the genetic background of the yersinia enterocolitica in food in China, so the strains can be used as the standard strains for scientific research and detection.
In addition, the yersinia enterocolitica inventors of the present invention provide a lyoprotectant having the following advantages: the molding is good, the appearance is beautiful, the water solubility is good, and the complete dissolution can be realized within 1 to 2 seconds; the freeze-drying survival rate can reach more than 85 percent; can be stored for more than one year at the temperature of minus 20 ℃, can ensure that the magnitude of the strain is not changed, and can be used for storing quality control strains for a long time.
Drawings
FIG. 1 is a colony morphology chart of Yersinia enterocolitica standard strain GDMCC60852 (gram stain, CIN plate, modified Y plate results from left to right).
FIG. 2 is a colony morphology chart of Yersinia enterocolitica standard strain GDMCC60853 (gram stain, CIN plate, modified Y plate results from left to right).
FIG. 3 is a colony morphology chart of Yersinia enterocolitica standard strain GDMCC60855 (gram stain, CIN plate, modified Y plate results from left to right).
FIG. 4 is a graph showing the molecular signature verification result of Yersinia enterocolitica standard strain GDMCC60852 (wherein the specificity of 5 specific genes of the strain is shown respectively).
FIG. 5 is a diagram showing the molecular signature verification result of Yersinia enterocolitica standard strain GDMCC60853 (wherein the specificity of 5 specific genes of the strain is shown respectively).
FIG. 6 is a diagram showing the results of molecular signature verification of Yersinia enterocolitica standard strain GDMCC60855 (wherein the specificity of 1 specific gene of the strain is shown respectively).
FIG. 7 is a graph showing the variation of bacteria content in the shelf life of different compositions of lyoprotectants.
Detailed Description
In order to more concisely and clearly demonstrate technical solutions, objects and advantages of the present invention, the following detailed description of the technical solutions of the present invention is provided with reference to specific embodiments and accompanying drawings.
Example 1 isolation and culture of Yersinia enterocolitica strains
Thoroughly shearing collected food samples under the aseptic condition, weighing 25g of the samples, diluting by 10 times, enriching by using PBS, and carrying out shake culture at 22-25 ℃ for 2-3d or standing culture for 5 d. Then, the mixture is treated by alkali (0.5 mL enrichment broth +4.5mL KOH) for 20 seconds, inoculated to CIN agar and cultured for 24-48 h at 30 ℃.5 representative colonies were picked and inoculated into nutrient agar and cultured at 30 ℃ for 24 hours. Adding the bacterial liquid into 25% glycerin tube under aseptic condition, and storing in-80 deg.C refrigerator. The purified colonies can be subjected to subsequent screening experiments as well as biochemical identification and biotyping.
Example 2 physiological and biochemical characteristics and serotype analysis of Yersinia enterocolitica Standard strains
Modified krebs test: 3 to 5 suspicious colonies obtained by separation are respectively selected and inoculated on the improved Ke-Di-saccharide iron agar, the slant surface is firstly scribed during inoculation, then the bottom layer is punctured, the culture is cultured for 24 hours at the temperature of 26 +/-1 ℃, and the culture which turns yellow and does not produce gas on the slant surface and the bottom is subjected to further biochemical identification.
Colony morphology: using modified Y plate culture, the colony morphology of Yersinia enterocolitica standard strain was a round, pink colony with bile precipitation rings at the edges (results are shown in FIGS. 1-3).
Urease test and kinetic observations: the suspected culture obtained by a full-loop modified Klebsiella biosciences test is selected by an inoculating loop and inoculated into a urea culture medium, the inoculation amount is enough, the culture is shaken for a few seconds, and the culture is carried out for 2 h-4 h at the temperature of 26 +/-1 ℃. The positive colonies of the urease test are respectively inoculated in two-tube semi-solid culture medium and cultured for 24h at 26 +/-1 ℃ and 36 +/-1 ℃. The suspicious bacteria culture with power at 26 ℃ and no power at 36 ℃ is streaked and inoculated to a nutrient agar plate for purification culture, and the purified product is used for gram staining microscopy and biochemical test.
And (3) dyeing microscopic examination: and smearing the suspicious colonies, performing gram staining, and observing the morphology by microscopic examination. All Yersinia enterocolitica are gram negative, rod-shaped or spherical, with size (0.8-3.0 μm). times.0.8 μm, no spores, no capsules, and periflagella.
API20E identifies: bovine-eye-shaped single colonies were scraped from the modified Y-plate, prepared into cell suspensions of appropriate turbidity using physiological saline, and identified using API20E biochemical identification test strips (results are shown in tables 1 to 3).
Table 1: yersinia enterocolitica standard strain GDMCC60852 API identification result
Table 2: yersinia enterocolitica standard strain GDMCC60853 API identification result
Table 3: yersinia enterocolitica standard bacterium GDMCC60855 API identification result
The strain has typical enterocolitis Yersinia biochemical characteristics: in the biochemical identification of API20E, the identification percentage of yersinia enterocolitica GDMCC60852 was 98.3% and the T value was 0.79. The identification percentage of yersinia enterocolitica GDMCC60853 was 95.4%, and the T value was 0.64; the percentage of identification of yersinia enterocolitica GDMCC60855 was 98.3% and the T value was 0.71.
Serotype analysis: five sera of O1, 2, O3, O5, O8 and O9 were used for agglutination test, and physiological saline was used for negative control. If the strain is self-coagulated in physiological saline to form a rough strain, the strain cannot be typed. 10 mu L of parting serum is taken and dropped on a sterilized empty culture dish, a proper amount of colonies are picked from an NA plate (or TSA plate) and smeared in the serum uniformly, the serum agglutination condition is observed, if the agglutination appears, the serotype is positive, if the agglutination appears, the serum test is carried out again, if the agglutination appears, O1 and 2 serum tests are carried out, and if the agglutination appears, O1 and 2 serum tests are carried out, if the agglutination appears, O3 serum tests are carried out. The identification result shows that the serotype of the standard strain GDMCC60852 is: o is 5; the standard strain GDMCC60853 serotype was: o is 8; the standard strain GDMCC60855 serotype is unknown.
Example 3 virulence factor carrying characteristics of Yersinia enterocolitica Standard strains
Identifying virulence genes carried by the strain by a PCR method. The primer used is limited by Shanghai biological organismSynthesis (primer sequences are shown in table 4). The PCR amplification system (25. mu.L) included: 2 × Ferent PCR mix, 12.5 μ L; 0.4. mu.M of upstream and downstream primers; ddH2O, 8.5. mu.L and genomic DNA, 2. mu.L. 8-10. mu.L of the PCR product was applied to a 1.5% agarose gel for electrophoretic separation (130V, 35 min) using 2000pb DNA Marker.
Table 4: primer sequences and amplified fragments for detecting enterocolitis yersinia virulence genes.
The enterocolitis yersinia standard strain carries virulence genes as follows:
virulence genes carried by the standard strain GDMCC60852 are: ystB-ymoA-fes-sat-inv-hrep-fepA-fepD-myfA.
Virulence genes carried by the standard strain GDMCC60853 are: ystB-ymoA-fes-sat-inv-hrep-fepA.
Virulence genes carried by the standard strain GDMCC60855 are: ystB-ymoA-fes-sat-inv-hrep-tccC.
Example 4 drug susceptibility characterization of Yersinia enterocolitica Standard strains
The drug sensitivity characteristic determination of the yersinia enterocolitica adopts a drug sensitivity paper sheet method, and the specific operation is as follows: activating Yersinia enterocolitica operating agar plate, adding physiological saline to dilute to final concentration of 1 × 107cfu/mL is coated on an MH plate, after the bacterial liquid is dried, an antibiotic paper sheet is attached to the surface of the culture medium, and the culture is carried out for 24 hours at 37 ℃. And measuring the size of the inhibition zone by using a vernier caliper to be accurate to 0.01 mm. The antibiotics selected were as follows: ampicillin (AMP, 10. mu.g), cephalothin (CF, 30. mu.g), amoxicillin clavulanic acid (AMC, 30. mu.g), cefotaxime (CTX, 5. mu.g), ceftazidime (CAZ, 30. mu.g), chloramphenicol (CHL 30. mu.g), kanamycin (K, 30. mu.g), gentamicinElement (GEN,10 μ g), streptomycin (10 μ g), sulfanilamide (SSS, 30 μ g), sulfamethoxazole (SXT, 25 μ g) tetracycline (TCY,30 μ g) sulfamethoxazole (SMZ, 25 μ g), imipenem (IMP,10 μ g), ticarcillin (75 μ g). The experiment used Escherichia coli ATCC 25922 as the quality control strain.
The drug resistance of yersinia enterocolitica standard strains is as follows:
the antibiotics tolerated by GDMCC60852 strain were: ampicillin (AMP,10 μ g); cephalothin (CF,30 μ g); sulfamethoxazole (SXT, 25. mu.g).
The antibiotics tolerated by GDMCC60853 strain were: ampicillin (AMP,10 μ g); cephalothin (CF,30 μ g); cefotaxime (CTX, 5. mu.g).
The antibiotics tolerated by GDMCC60855 strain were: ampicillin (AMP,10 μ g); cephalothin (CF,30 μ g); sulfamethoxazole (SXT, 25. mu.g).
Example 5 Multi-site sequence (MLST) typing analysis of Yersinia enterocolitica Standard strains
The primers used in this experiment were synthesized by Ongchoma BioLimited, Guangzhou (primer sequences are shown in Table 5) using the protocol required by the MLST official network. Reagents used for fragment amplification include: PrimeSTAR Max DNA Polymerase (Takara).
Table 5: yersinia MLST PCR amplification primer table
Note: rfaE was used exclusively for amplification of O:3 serotype yersinia enterocolitica.
The PCR reaction system is 50 μ L: 2 × PrimeSTAR Max DNA Polymerase 25 μ L; 1 mu L of each upstream primer and downstream primer; 1 mu L of DNA template; the volume of the solution was made up to 50. mu.L with ultrapure water.
The PCR reaction conditions are as follows: first stage-pre-denaturation at 95 ℃ for 5 min; second stage-denaturation at 94 ℃ for 30 seconds, annealing for 30 seconds (temperature depends on primer), extension at 72 ℃ for 30 seconds; third stage-extension at 72 ℃ for 5 minutes, and finally 4 ℃. Wherein the second phase is repeated 30 times.
After the PCR amplification was completed, the product was subjected to agarose gel electrophoresis to determine the size of the product. The correct size product was sequenced (Ongzhou Onghama Biotechnologies, Inc.). And after the sequencing result is determined to be good, searching the corresponding MLST type by using the sequencing result.
The results of yersinia enterocolitica standard strain MLST are shown in table 6:
table 6: yersinia enterocolitica Standard Strain MLST typing
Example 6 signature sequence analysis of Yersinia enterocolitica Standard Strain
The screening of the characteristic sequences of the yersinia enterocolitica GDMCC60852, GDMCC60853 and GDMCC60855 is mainly based on the result of the pan-genomic analysis of the yersinia enterocolitica to screen the non-essential genes specific to the strain. The genome sequences of 253 representative yersinia enterocolitica strains (containing the yersinia enterocolitica strain of CMCC 52204) were selected for pan-genomic analysis. The Pan-genome Analysis adopts an MP method in prokaryotic Pan-genome automated Analysis software (PGAP), and the Analysis result is processed by a local Perl script to obtain the core gene and non-core gene information of all strains. Then selecting the specific genes of the three strains, and removing non-specific sequences through local Blast comparison. Primers are designed aiming at the finally selected specific sequences, PCR amplification verification is carried out, and the verification result is shown in FIGS. 4-6.
Yersinia enterocolitica GDMCC60852 has 5 unique genes, respectively numbered GDMCC60852_00002, GDMCC60852_00642, GDMCC60852_00654, GDMCC60852_ 02222 and GDMCC60852_ 02225, and its nucleotides are as shown in SEQ ID NO: 1-5, can be amplified and verified by the following primers:
table 7: molecular tag primer sequence of yersinia enterocolitica standard strain GDMCC60852
Yersinia enterocolitica GDMCC60853 has 5 unique genes, which are numbered GDMCC60853_01766, GDMCC60853_01769, GDMCC60853_01770, GDMCC60853_ 01773 and GDMCC60853_01774 respectively, and the nucleotides of the genes are shown in SEQ ID NO: 6-10, the amplification verification can be carried out by the following primers:
table 8: molecular tag primer sequence of yersinia enterocolitica standard strain GDMCC60853
Yersinia enterocolitica GDMCC60855 has 1 unique gene, is respectively numbered as GDMCC 60855-04389, and has nucleotide shown as SEQ ID NO:11, the following primers can be used for amplification verification:
table 9: yersinia enterocolitica standard strain GDMCC60855 molecular tag primer sequence
The invention also provides a freeze-drying protective agent for quantitatively storing the yersinia enterocolitica standard strain, and the components of the freeze-drying protective agent in different examples and comparative examples are shown in the table 10:
table 10: components of each group of freeze-drying protective agent
The parts by weight of the skim milk powder were increased in the comparative example to make up the total amount due to its lack of components.
The freeze-drying survival rate of the freeze-dried strain (GDMCC 60852) of the protective agents in examples 7 to 9 and comparative examples 1 to 3 is tested by the following specific method:
after the recovery of the strains, inoculating the strains into a culture medium, culturing until a proper amount of the strains are selected and added into the protective agents of the examples 7-9 and the comparative examples 1-3 at the early stage of the logarithmic phase to the stationary phase, uniformly mixing, subpackaging the mixture into penicillin bottles, taking samples, diluting and counting to obtain the bacterial content A0 before freeze-drying. Transferring the half-stoppered split penicillin bottles into a freeze dryer for pre-freezing at the temperature of minus 40 ℃ for 3 hours, starting main drying for 20-25 hours, then entering an analysis drying stage for 6-8 hours, finishing drying, pressing the stoppered split penicillin bottles in a vacuum state, moving the split penicillin bottles out of the freeze dryer, automatically capping the split penicillin bottles, ensuring the complete vacuum state of the samples, and storing the split penicillin bottles at the low temperature of minus 20 ℃. The freeze-dried samples were diluted and counted, the count result is the freeze-dried bacterial content A, and the freeze-drying survival rate is the percentage of A to A0, and the results are shown in Table 11:
table 11: comparison of freeze-drying survival rates of different compositions of lyoprotectants
As can be seen from Table 11, the lyoprotectant in example 8 is the best example of the present invention, and therefore, comparative examples 1 to 3 are prepared by taking example 8 as a comparison object, and as a result, as shown in Table 11, the protective effects of comparative examples 1 to 3 are all worse than those of the examples due to the absence of one of the components of the lyoprotectant in comparison with the other examples, which indicates that the components of the lyoprotectant in the present invention, namely sodium glycerophosphate, polyvinylpyrrolidone and reduced glutathione, have a synergistic effect, and the absence of any one of the components cannot achieve the effect of the protectant in comparison with the other examples.
The freeze-drying stability of the freeze-dried strains of the protective agents in the embodiments 7-9 and the comparative examples 1-3 is compared, and the specific method comprises the following steps:
quantitative quality control bacteria were prepared using different protective agents according to the preparation method of example 7, stored at-20 ℃, and 3 were extracted every month to check the bacterial content according to the aforementioned counting method. In order to better compare the effect of each protective agent in the long-term storage process, the number of viable bacteria before freeze-drying is calculated according to the freeze-drying survival rate of each protective agent when quantitative quality control bacteria are prepared, so that the bacteria content of each protective agent is about 3000 cfu/bottle after freeze-drying.
As can be seen from the attached figure 7, the bacteria content of the quality control bacteria protected by the freeze-drying protective agents of the embodiments 7 to 9 has no significant change after 12 months of storage, while the bacteria content of the quality control bacteria protected by the freeze-drying protective agents of the comparative examples 1 to 3 is significantly reduced after 2 months, and the bacteria content is close to 0 after 12 months.
The above-mentioned embodiments only express several embodiments of the present invention, and the description thereof is more specific and detailed, but not construed as limiting the scope of the invention. It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the inventive concept, which falls within the scope of the present invention. Therefore, the protection scope of the present patent shall be subject to the appended claims.
SEQUENCE LISTING
<110> Guangdong institute for microbiological analysis and detection (Guangdong center for microbiological analysis and detection) Kyork Biotech Co., Ltd
<120> Yersinia enterocolitica standard strain containing specific molecular target, detection and application thereof
<130> 12.11
<160> 33
<170> PatentIn version 3.3
<210> 1
<211> 2652
<212> DNA
<213> bacterium
<400> 1
atggccaaca gacatcacag tgataattcc accacgcccg aacgtgtacc tctgcacgct 60
tttcagcgtt cagtctggct gacattcggt gagcaaagcc tgcccctgcg ggagcaaatc 120
gctctccatg aggcgcgttc actgtccatt gcctcacgga tacaacgcga ccgcgcccgg 180
caggagcgtg acgaatggat gaaagcgctg cattcatggg ataaaaccat cgaaggcgtg 240
cgcgaacgtt tttatgccca gccctttttt attcgccaga cctttcaaaa caaaatcgcc 300
tcatttcgcg atgaagaacg tctcaatgcc tttttcatga ataccgtgaa aaacgcattg 360
ctgcgtctgg aggccgtcaa acgcctgcac tgtatcaacc gcgctcacac ctcggagcta 420
tctgcctatt accatgccgt gtggccgcgt ctggtggaaa aagaccggcg cagtattctc 480
agtctggcta atggactggc ggcacgtatc aacgagatga tctataccga gtgtgaccag 540
cagcccgaac tcaaaagtga cgactacctg cataacattt atcgccatct gaccattgag 600
ttgtttgctc tgcgtatcac cgcccccatg ccgtatctgc gcgactggcg caagttcaac 660
cgcccggact ttttctcggc ggctgcgcgg ctctgtagcc cggagtggtg ggggcgtaaa 720
ttgtggcgct tacgcaccca gtggcgcgaa cagcagttac gcgctgtcag cacggtacat 780
cgtttcgcct ccccctatat cagcagtgac gccctgcaac actggctaca ccagcgccgc 840
aaaaatctgg cgttcctgca aacccatgag ctggtcgatg acgaaggtaa tgtgtattca 900
ctggaggcaa tggcgatggc cagtatcagt aatccggtct tacgccgcca cgaactgatg 960
gctcgtgttt ccggagtgga ggccgtggcg aatgagcggg gagattgcgg ggtgtttctg 1020
accgcgacca ccccgtcaaa atatcactct aactatcagg tcagcggggc catgaatgac 1080
aaatggaacc acagtaccgt ggaagaggcg caccgttacc tgatggacac atgggaactg 1140
gcgtttaccg cgttaagaaa ccaaggcctg cgtccttacg gtttccgggt tatcgaacct 1200
catcatgatg gcacgccaca cctgcactgt tgcctgttta tgcccaaagc acagcgccct 1260
caaatactca aaatattgcg tcgctatttc attgcagaag accgcgaaga gctgggtaaa 1320
aacctaacag cgcgcttcaa ggtggagtac atcaaaccca gtaaggggac ggccacttcc 1380
tacgcagcca aatacatcag caaaaatatt gacggttacg cactggaggg ggaaatcgac 1440
cacgaaaccg gccgcccgct ggcagaaacc gcccgccgcg ctatggcgtg ggcatccacc 1500
caccgtatcc gccaatacca gtttgtagga acaccaccgg taacaccgta tcgggagcta 1560
cgcaaactta gtaaccggat ggaagcgcaa ctgaaacacg cccgccagtg gaagcccgga 1620
caatctttgt taaccgatac agccatggac agggtgatgg ccgcagccga tgccgggtgt 1680
tttgccagct acatcaaggc acagggaggc gttctcattc cccgcaagga ttacaccgtc 1740
gcactggcct atgagcttgc cgataaaccc aatgcttacg gtgaaatcac ccccaaaatc 1800
tttggtatct ggtcacccaa taaaggggaa gacaccaaaa tctgtacgcg gcaaaagacc 1860
ttcactatcc gcaaaaaaga gaagccaaaa accgtcgacc ttatggagaa gttaggcacc 1920
ccgtgcggca ccgccgcccc ttggagtcct gtcaataact cgacagagga gaaaaaacag 1980
ccagaaaatg acgaaaacca caccacacaa gaaaccggtg aagagcagga aatcaccgac 2040
tttaacacca ttacccacaa acagcgccgc gcattgctca agcgattgcg acaaatgcca 2100
cctgtttgca ccaaagcccc aattgccacc gcaccagacg aattactggc cgcccaacgt 2160
gcacaggaaa aacgccagca ggccgcccaa cgccgtcagc accggctgca cctgctcaat 2220
acccatctgg aagatatcgg ggaaaacctg cccccgctgg cgcgcaccat tctggccgat 2280
ggcggcagct attacaccac cacacgctgc tatcgtctga ccgaacgcgg ggaactgctt 2340
tgcctgccct atcgtccacg tccggataac cagcaaaaag cggcactgtt caatgaacgc 2400
gtctcacgca tcaatcaaat actgacacag cacaacgctg caccgctgtc acaggaaagt 2460
tcactggcgg agaaaatagc ccgacataat gatttactgc aaaaacacac ccaggtaccg 2520
ctggctattc agccagtaac cacaaaacca acaccggagg aaaaacaaca agcccgaaac 2580
gtggcgcact ttgcccagaa aatgcgccac ctgtttctgc agttcaaagc aaagcaacac 2640
agtgctgact aa 2652
<210> 2
<211> 906
<212> DNA
<213> bacterium
<400> 2
atgcctaagt ataaaatgga tatattgaac aatgctattg atagtctcaa tgaatctctt 60
gataaatacg atcagggaca ggcaggtaat ataaggcaac ataaatttgc attacttcat 120
ttttgtcatt tcatggagtt agcccttaaa tactatttaa caacaaaaaa tgaaaatcta 180
atctataaaa aggtatatat ttatattaaa aataaagcta agagtgaaaa gatttctcta 240
tcagatgcat atgacaaatt agaagatgaa gattttgatt tcaatgagtt acttgttggt 300
gactctaatc cattcacaat aacagcagat caagcattag cctttattaa atcagacgat 360
gcaggtattg atgatgaact tatttcagag atatctgcta tgaaacaact gagaaataac 420
attgaacact gtcgttttga gatggatact aaagatgttc gattagctct aggccggtta 480
actcgtggat ttgatcaatt ctatgaatat gttggtttcg gtgagttaca acattcagta 540
aataaagcac agttgggtat atttcaaact ttagccaatg aatatgatca taacttatcc 600
gaagcgaaag cagatgctca ggaagctcac agggatgcat ttcgcggggt taggctgaag 660
cattatgaat tcgttaactt cacgacttat gattgtcatg aatgtaatca aactaaccta 720
atgataccta atgaagaatc tccttcagga tatcgttgta cgcattgtgg caacgaagag 780
tctgacgata ttgaggttga atgtgaaatt tgtggtggaa tttggcctaa tggggacatg 840
tgttcttggg aggatacata tgattatact tgccctgact gcaatgactt ctctagcaga 900
gattga 906
<210> 3
<211> 1800
<212> DNA
<213> bacterium
<400> 3
atgaataaga tagggaatgt gatttccagt tctcctgaac ttataagaat tcagatggaa 60
ggaaaagata ctttagaaaa acataagaca caactgcaag ttggttcctt tttaaaaata 120
gaagatggaa accataatta tgctgttgca acaataaaaa atcttactgg acaatacaat 180
gaaaaagaag atggacctaa ttggatattt ataatagagg catctcctat aggtgtccta 240
accaatgaaa atgatttgtt aattttttcc agaggaacac aagtacttcc tgtcccaaca 300
gaattagtgt atacatttga agataatgac ttgaaatcaa ttttctctga aggaggtggt 360
gattttaatt ttagaatagg tagcttatct aataatcaga aaatcccttt ttatatagat 420
ggcgacaaat tttttagcaa acatattggt gttgttggtt ctacagggtc agggaagtcc 480
tgcgcagttg caagtttgat tcaaaatatt gtaggcatat ctgaatcaaa aaatattttt 540
aaaggcagta ttaagaactc tcacgtattg atatttgata ttcattctga atactcttca 600
gcatttacta tggaaagaga agaagagttt agtttgaatg ttttaactgt tgataacttg 660
tgtttacctt actggcttat gaattcagag gaaattgagt ctttatttat tgaaagtaat 720
gagcaaaatt ctcacaatca agtatctcag ttaaaacgtg ctgttatttt aaataaagaa 780
aaattcaacc ctaaagtaga taatataacg tatgacagtc cagtctattt tagcattaat 840
gaagtttata attatatctg caataaaaat gatttaaccg tttatgaaaa agattcaaag 900
ctatatctag ccacattcga ttttgatgaa gaatataaag aggacttgct tttttcaaaa 960
ataaactttg aaaaagccac aggaaatgca aaacataaaa tatttgatga aaaagtatct 1020
aaatatggtg gtttcaccgg cgatttcgaa agattcatat cgagatttga aacaaaacta 1080
catgatagac gacttaagtt tcttttatct ccagaattac cccctttaaa agagataaga 1140
tctaaagatt ttgaaacgat attaaaacaa ttcttaggat ataataacaa ggctaacatt 1200
tcgatagtag atttgagtgg aattccgttt gaagttttga gcttaacagt tagtttaatt 1260
tcaagattaa tgtttgattt tgcatttcac tattcaaaaa tgatgcattc aaaaaacaaa 1320
acaaatgata taccgttctt aatagtatgc gaggaagccc ataattacat acctaaagat 1380
aactcttttg aatttaaagc atcacgaaaa tctatcgaac gtattgctaa agaaggaagg 1440
aaatatggtt taagcctaat ggtggtaagc cagcgacctt ccgaagtttc cgatacaata 1500
ttttcccaat gtaataactt tttatcattg agacttacaa ataagaacga tcaaggatat 1560
ataaaagcat tattgccaga tggtgccaat gggttagttg atttattgcc tagtttagga 1620
caaggcgagg cctttattgt tggagatgcg attttaatgc ctagtttagt aaaattacct 1680
cgcccttccc cagaaccaag ctcagcaagt ataaaagttt ataaggaatg gaactcagtt 1740
tggaaagaag ctgaatttaa taagcttgtc gaacgatggg gtaaaaatag tgataattaa 1800
<210> 4
<211> 1107
<212> DNA
<213> bacterium
<400> 4
atgtcaattt cacttgaact gcaaaaaatt gctgataatt taaccgcatt tgagaataat 60
gaattagatg agattgatca tttaatcgat ataacagaag aaatatctaa gtcattttca 120
ggttcatggt ttggctatca ttctcgagtc tattacagag atttcaacac tcctccatca 180
ggtgccatat ttagtgctga atgggggtta atggattcat tctcaatggg gtcggttggt 240
gattgggtgg aataccagta tgatgccgtt attaattata ttcataatga atggaatgat 300
aatgagttag atgaatatat aaaaatttct aataaggcaa actcaatatt cgaagtgtgt 360
aaaagtgaca ctttatctct tatttattca aataaagaga ctcttgatga agataagttc 420
ttgatggatt taatcgagaa aatagaaaaa acaaaagtga ttgttgaaaa ccaatttata 480
agttattacc gaccaaatcg tcaaataatg actcgtgata tgaatgcgat aaacaatggt 540
ttacaaacgc cacctcatat cgcagtgtat tgcaaggcaa tgagtataaa atcaccatat 600
atgtcttgtg gagaattaaa ggtaaatctg ataaagcttt ctaatcatat taaaaataaa 660
gaaaagaaat cagttattga agagagaatc ggtgtgaata ttttcatcgg tcatggacgc 720
tctcatatgt ggagagagct taaagatttt gtccaggata agctaagact accttatgat 780
gaatttaatc gtgttccagt ggccggagtt acaaatataa ctcggttagc tcaaatgctg 840
gatcaagcat gcattgcctt tttaatcatg acagctgaag acgagttact ggatggcaat 900
aagcaagcta gaatgaacgt tattcatgaa gtaggattat ttcaaggacg tctgggtttt 960
gagcgagcta tagtcttatt ggaagagggt tgtgaggagt ttacgaacat taatggtctt 1020
ggccaaataa gatttcctaa aggtaacatt tccgcagtat ttcaagatat tcgagaagtc 1080
ttggaacgag aggatataat aaagtag 1107
<210> 5
<211> 1389
<212> DNA
<213> bacterium
<400> 5
atgggaaatg ataagtccat ctgccatcaa tgtgtgggtg aaaagtttat cagtgccatg 60
attaaaaaaa agggtagtgc taatgatcgt tgtagctact gtaggagcag aagaaaaaca 120
atctctctgc ccgagttagc tgaatccatg cacacagtgt tttctaccta ttacagatgt 180
agagctgatg agggactcta tcccggctac agtttcggta atccagcgga ggatattatt 240
gctgaatgcc tcgaagtaga tgaagatatt tccgcagaga ttcatgaagc tctgaaggaa 300
aactataatg acgggtttga cggtgatgtt tacagcgagg attacgttta caaagaaaaa 360
acccactctt ccgaagctct ggataataaa tgggaagaga taaaaaagtc cctccagaac 420
gaagcacgat tttttaataa tcacgtaaaa gatttttttg ataaaatatt tagcggtatt 480
gaaacacacc ggacgcaaga cggcaggagc gcggttaatt atattaataa tgatatgcca 540
gtatttaggg cgagggtctt tgacagctat gacaaggtag aagaagcact tcaacatcct 600
gagagacact tcggcccgcc cccgcatttg ctagctactt cgggccgcat gaatgcgcaa 660
ggcattcccg tcttctacgg agcctcgtcc cctaatatcg ccatcgcaga agtaagacca 720
gcggtaggta gccttgtcgt cgtagcgcag ttcagccctt tgaagccctt acggattttg 780
gaaatttccg ctctggatga actgagtact atcaaaaata gtttattcga tcctcagacg 840
gctgaaaagt ttgccacggc ctgctttctg cgaaagcttt cccgcaaact gacactacca 900
gtttcaggga aaaaaactga cactgaatat ctcattactc aggctatttc cgaataccta 960
tccttatcag acatatataa acttgacgga atcagtttta aatcaacaca gcaaacctat 1020
gagaaaaatg aattctccac tccctacaac attgttctct tcaatagatc atcagcagtt 1080
ctgaatgcgg atgttcaaaa cacgagatat tcagtaaaca tttttgaata cgacgatgac 1140
gacgagacga gttattcctg gttggaacca gaaatacgga aaattgaaac cgtttctgat 1200
aaattatcca tatcccgtca acatatatcc ctgaaagact attcccttca gttaaatgcc 1260
agtgagatga ctttccatat aattaaaggg gttgtatacc agaagactga gtacccaatc 1320
aggctgggta aacctaagct tatgaaagca gatagctctc atgagttttt tggtgacgaa 1380
ccattttga 1389
<210> 6
<211> 756
<212> DNA
<213> bacterium
<400> 6
atgtcattcg ctaaatgccc tatctctggg accactaagc cagcccctca cagtgtccct 60
aagttcctga ttgacccatt gaccaatgtg ttcactacac gcagtgctct ctctaaagaa 120
tccagagcct atgctcgtat ctatggagca actgctatca ctggtactct ctataaagag 180
tcattacctc ctaaggcccc tacagttaag actaacagta acgctctgac ccatgaggac 240
attaagaccc gcttcgttat cagtgagtca tcaccctcag gtctcgcaga tattcgcagt 300
ggtaagcctg taggctctaa ggggtcttac tggcgtgtag ctgtaagtgc tggtgttacc 360
cagatggtcc ctgactatcg cactggtggc ctccgtaagg cctataagaa cctcacagcc 420
gcagctcacc gagtggtctt tatgttgaac cataagagag acattaaggt aggctgtatc 480
gttactcacg ttaatggtga ctcatatgac aatagaccct gtaacctcct tgaggtgtcc 540
cagagcgcca cagcgttgca ccgtaaggct tcccagagag ttagcgataa ggcctatgtt 600
ggagttggct acgtgaagcg cagagagtgc tatgtgggcc gctgtaaggt ccaaggtatc 660
atctattaca ctaagggcta taaggatatc aatatgtgtc ataacgcctt agtgaagctc 720
agagagactg taggcgcacc tgctgtagcc ctttaa 756
<210> 7
<211> 1158
<212> DNA
<213> bacterium
<400> 7
atgagtagca ataaattcac ttctgctggc aacaccaacg ctaacactcc acgagtaggc 60
aataaggcct ctaatctgtc cgagctgggc cgtcacctgc aagactctga tggtatggct 120
gtaccgaact ccgtatgggg tactgacatt gaccgcactg agtacgtgga gatggtcggt 180
gagaacacat ctatccttaa cttaggtcat acagaccgct caggtcgccc tatggcattc 240
ggtaatgact ctcatgacta tgtgcaagcc ttagaggcct ctctggatgc aacctttaac 300
gatggtgaat tcgctcaggt catgcaggag catattttcc cttgtgagtt ccgtccgttt 360
ggtacacagc ctaccccatt gaacatccag ttacttgaag accgctcagt gacctttaac 420
ccagagggta agctggaccg ctctaagttg cctaaaggta aagccattgc tggtagttca 480
atcatggtcg ctcctgtact tcatggtgac gataagaccg agacaggtat tctgtgctca 540
gtggctactc acgtatcaga ctttgatatg atgggcggtt ggactgatgg cagcttacgc 600
caaactgtag gtaacatgca gctgcaattc tgccgtgtcc tgtcaggcca agtagccaag 660
gtcctatcta agaccccaga cctacagacc cttgagtgtg aagctctaag cgttaaacct 720
gctgaggccg ctgaggacct gctggatgct ctggctacct ctatgcctac tcacttaggt 780
gctaccttgg acctatacgc cttgatggtc ccagagaagc tggaaggtgt cttagagcgt 840
gctgctcaac gtgcaggtca tgaagatgcc tctgagctgt tcggttgtac catcatgggt 900
tatgtaggtg aagatactgg tgtctacttg ctgcctaaag cattcgctat gatttctttc 960
cgttcaacca aagagggtga cacagttaag attgttatca ctcgtgacac taaccgctca 1020
ggctatgctg tagagatggt ctcagtgttg gacgttatgg caactggcac cgttaaggtt 1080
aaacatggtg agttcgataa ggaatccgta gcggagttcc cagtggtcca tcgcctgacc 1140
tttaaggcaa gctcatag 1158
<210> 8
<211> 411
<212> DNA
<213> bacterium
<400> 8
atgagtatct cattccgtaa attagaccta actgtatccg cagatggtca aaccgtcttg 60
gtgttcggcc aagagttcgc cgctaagtat ttctctgagg ttgtggtaac taccatgctg 120
aatagcgtag gtgacccatc attcaagtct aacaatatcc tcaataactt acatgctgct 180
ggccttaatg ctggtgacta tggggtttac tctaagttct ggggtatgag caatcaagaa 240
gctcgtgagc aagcagagca tgaacgccgt gaagcccaga aacacttgga gcgtgtgcgt 300
gacatgatgg caacacctgc tgacatcgct aaggaagcct ctaagaaacg tgagactgct 360
gaccgtatgg aacgtatgta cggacgtaaa ggtgcagctt tcggcctgta a 411
<210> 9
<211> 246
<212> DNA
<213> bacterium
<400> 9
atgattatcg acattattgc tatcagcctc atcttagtgg tcatgtatat ccgtagaagc 60
caatccgctg acctgcattg tagatactta cagctatcca gcttgggcta tgagtccata 120
gagctgatgt gtacagatga tagattcgct aaggcctaca gacacactaa gttactgaca 180
acggtcctaa ggattctcgt agttggctat gctgcctcat gggtggtaac tctgctcagt 240
cgatag 246
<210> 10
<211> 231
<212> DNA
<213> bacterium
<400> 10
atgtttacta accctatcac cttaatcatg accaccttca atggtcttat agtggtcctt 60
ggcttgtcta atggttccac tccaagtgta gccttaggcg ctggtctgtt cgccttactg 120
tttatcaatt gggtgactga cggtaactct aagttctggg agtccttggc tatgtggtcc 180
tacccgctca ccgtagcgtg tgcctttctg agcctgagct tggctttctg a 231
<210> 11
<211> 999
<212> DNA
<213> bacterium
<400> 11
atgatttttg agcttgcttt tctgtttttc tcttcattca ctaccttgtt tttaatgaga 60
aaagtcgcaa aacgcattgg tttggttgac aaacccaatg caagaaaact acacgaggga 120
gcgattcctc ttgtcggcgg aatttctatc acattggtgt tagctcaatt tcttatttat 180
aaacctgatc taatcaagca cagcgggtta tttattattt caattatggt gctgacttta 240
attggcgctc ttgatgataa atttgaccta agcgttcgcg tgcgtattgg ggtgcaaacg 300
gttctctctt tagtcatgat gcatattggc gggctagagc ttcaccacat tggtaatatt 360
ttaggctttg gtgatattta tctaggctgg ataggaagcg tcattaccat tatggcagtg 420
attggagcaa ttaatgcctt caatatggtg gatgggattg acggcctgtt aggcgggctt 480
tcgattgtga cttttggtgc attagccttc ttattgaaag tagacagcca acatgggttg 540
gcttatctat gcgtggtgat tattgtggcg atgctacctt atatttgtat gaacctcggc 600
atattaggac gtaaacgtaa agtctttatg ggtgatgcgg gaagcatgat gataggcttt 660
actgtgattt ggatgctatt aggcgtcagc caagttgatg caaaaccact catgcgacca 720
gttacggctt tatggcttat cgcggtaccg ctcatggaca tgactgcaat tatgatccgt 780
cgcatacgac gcggagactc accatttaaa ccagacagag aacatttgca tcatatttgt 840
cagcgtttag gccttagctc tcgacaaaca ctagtagcca tttgctctgt tgccattctg 900
ttcgccagtt ttggtattta cggtgaagcg gttaatttaa ctgaagctgt catgttttat 960
agctttatcg gcagcttttt atttactcac tactattaa 999
<210> 12
<211> 19
<212> DNA
<213> Synthesis
<400> 12
atggccaaca gacatcaca 19
<210> 13
<211> 21
<212> DNA
<213> Synthesis
<400> 13
ttagtcagca ctgtgttgct t 21
<210> 14
<211> 19
<212> DNA
<213> Synthesis
<400> 14
tgcctaagta taaaatgga 19
<210> 15
<211> 21
<212> DNA
<213> Synthesis
<400> 15
agagaagtca ttgcagtcag g 21
<210> 16
<211> 21
<212> DNA
<213> Synthesis
<400> 16
agggaatgtg atttccagtt c 21
<210> 17
<211> 20
<212> DNA
<213> Synthesis
<400> 17
ttttacccca tcgttcgaca 20
<210> 18
<211> 21
<212> DNA
<213> Synthesis
<400> 18
tgtcaatttc acttgaactg c 21
<210> 19
<211> 21
<212> DNA
<213> Synthesis
<400> 19
tcctctcgtt ccaagacttc t 21
<210> 20
<211> 20
<212> DNA
<213> Synthesis
<400> 20
tccatctgcc atcaatgtgt 20
<210> 21
<211> 21
<212> DNA
<213> Synthesis
<400> 21
ggttcgtcac caaaaaactc a 21
<210> 22
<211> 21
<212> DNA
<213> Synthesis
<400> 22
tcattcgcta aatgccctat c 21
<210> 23
<211> 20
<212> DNA
<213> Synthesis
<400> 23
ttaaagggct acagcaggtg 20
<210> 24
<211> 20
<212> DNA
<213> Synthesis
<400> 24
attcacttct gctggcaaca 20
<210> 25
<211> 20
<212> DNA
<213> Synthesis
<400> 25
tgagcttgcc ttaaaggtca 20
<210> 26
<211> 21
<212> DNA
<213> Synthesis
<400> 26
tctcattccg taaattagac c 21
<210> 27
<211> 20
<212> DNA
<213> Synthesis
<400> 27
aaagctgcac ctttacgtcc 20
<210> 28
<211> 19
<212> DNA
<213> Synthesis
<400> 28
ttgctatcag cctcatctt 19
<210> 29
<211> 20
<212> DNA
<213> Synthesis
<400> 29
agcagagtta ccacccatga 20
<210> 30
<211> 21
<212> DNA
<213> Synthesis
<400> 30
ctaaccctat caccttaatc a 21
<210> 31
<211> 19
<212> DNA
<213> Synthesis
<400> 31
aaagccaagc tcaggctca 19
<210> 32
<211> 20
<212> DNA
<213> Synthesis
<400> 32
tgcatattgg cgggctagag 20
<210> 33
<211> 20
<212> DNA
<213> Synthesis
<400> 33
cagtcatgtc catgagcggt 20
Claims (2)
1. Application of primer for detecting specific molecular target in preparation of yersinia enterocolitica: (Y. enterocolitica) The application of the strain detection reagent is characterized in that the specific molecular targets are as follows:
1-10 of any one or more nucleotide sequences shown in SEQ ID NO;
wherein, the primer for detecting the specific molecular target shown in SEQ ID NO. 1 is used for preparing the yersinia enterocoliticaY. enterocolitica) The detection reagent of the strain C009 with the collection number GDMCC 60852;
wherein, the primer for detecting the specific molecular target shown in SEQ ID NO. 2 is used for preparing the yersinia enterocoliticaY. enterocolitica) The detection reagent of the strain C009 with the collection number GDMCC 60852;
wherein, the primer for detecting the specific molecular target shown in SEQ ID NO. 3 is used for preparing the yersinia enterocoliticaY. enterocolitica) The detection reagent of the strain C009 with the preservation number of GDMCC 60852;
wherein, the primer for detecting the specific molecular target shown in SEQ ID NO. 4 is used for preparing the yersinia enterocolitica: (yersinia enterocolitica)Y. enterocolitica) The detection reagent of the strain C009 with the collection number GDMCC 60852;
wherein, the primer for detecting the specific molecular target shown in SEQ ID NO. 5 is used for preparing the yersinia enterocoliticaY. enterocolitica) The detection reagent of the strain C009 with the collection number GDMCC 60852;
wherein, the primer for detecting the specific molecular target shown in SEQ ID NO. 6 is used for preparing the yersinia enterocoliticaY. enterocolitica) The detection reagent of the strain Y802 with the collection number of GDMCC 60853;
wherein, the primer for detecting the specific molecular target shown in SEQ ID NO. 7 is used for preparing the yersinia enterocoliticaY. enterocolitica) The detection reagent of the strain Y802 with the collection number of GDMCC 60853;
wherein SEQ ID NO 8 is detectedPrimers specific for the molecular targets shown for the preparation of Yersinia enterocolitica: (Y. enterocolitica) The detection reagent of the strain Y802 with the collection number of GDMCC 60853;
wherein, the primer for detecting the specific molecular target shown in SEQ ID NO. 9 is used for preparing the yersinia enterocoliticaY. enterocolitica) The detection reagent of the strain Y802 with the collection number of GDMCC 60853;
wherein, the primer for detecting the specific molecular target shown in SEQ ID NO. 10 is used for preparing the yersinia enterocoliticaY. enterocolitica) The detection reagent of the strain Y802 with the collection number of GDMCC 60853.
2. The use according to claim 1,
the primer aiming at detecting the specific molecular target shown as SEQ ID NO. 1 comprises: an upstream primer shown as SEQ ID NO. 12 and a downstream primer shown as SEQ ID NO. 13;
the primer aiming at detecting the specific molecular target shown as SEQ ID NO. 2 comprises: an upstream primer shown as SEQ ID NO. 14 and a downstream primer shown as SEQ ID NO. 15;
the primers for detecting the specific molecular target shown as SEQ ID NO. 3 comprise: an upstream primer shown as SEQ ID NO. 16 and a downstream primer shown as SEQ ID NO. 17;
the primers for detecting the specific molecular target shown as SEQ ID NO. 4 comprise: the upstream primer shown as SEQ ID NO. 18 and the downstream primer shown as SEQ ID NO. 19;
the primers for detecting the specific molecular target shown as SEQ ID NO. 5 comprise: an upstream primer shown as SEQ ID NO. 20 and a downstream primer shown as SEQ ID NO. 21;
the primers for detecting the specific molecular target shown as SEQ ID NO. 6 comprise: an upstream primer shown as SEQ ID NO. 22 and a downstream primer shown as SEQ ID NO. 23;
the primers for detecting the specific molecular target shown as SEQ ID NO. 7 comprise: an upstream primer shown as SEQ ID NO. 24 and a downstream primer shown as SEQ ID NO. 25;
the primers for detecting the specific molecular target shown as SEQ ID NO. 8 comprise: the upstream primer shown as SEQ ID NO. 26 and the downstream primer shown as SEQ ID NO. 27;
the primers for detecting the specific molecular target shown as SEQ ID NO. 9 comprise: an upstream primer shown as SEQ ID NO. 28 and a downstream primer shown as SEQ ID NO. 29;
the primer aiming at detecting the specific molecular target shown as SEQ ID NO. 10 comprises: the upstream primer shown as SEQ ID NO. 30 and the downstream primer shown as SEQ ID NO. 31.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011615514.XA CN112795669B (en) | 2020-12-30 | 2020-12-30 | Yersinia enterocolitica standard strain containing specific molecular target and detection and application thereof |
PCT/CN2021/087078 WO2022141943A1 (en) | 2020-12-30 | 2021-04-13 | Yersinia enterocolitica standard strains containing specific molecular target, and detection and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011615514.XA CN112795669B (en) | 2020-12-30 | 2020-12-30 | Yersinia enterocolitica standard strain containing specific molecular target and detection and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112795669A CN112795669A (en) | 2021-05-14 |
CN112795669B true CN112795669B (en) | 2022-05-20 |
Family
ID=75804684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011615514.XA Active CN112795669B (en) | 2020-12-30 | 2020-12-30 | Yersinia enterocolitica standard strain containing specific molecular target and detection and application thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112795669B (en) |
WO (1) | WO2022141943A1 (en) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197514B1 (en) * | 1999-04-12 | 2001-03-06 | Becton, Dickinson And Company | Amplification and detection of Yersinia enterocolitica |
WO2013016129A1 (en) * | 2011-07-25 | 2013-01-31 | E. I. Du Pont De Nemours And Company | Method to amplify nucleic acids to generate fluorescence labeled fragments of conserved and arbitrary products |
CN111549147B (en) * | 2014-12-11 | 2023-02-03 | 中国科学院上海营养与健康研究所 | Rapid bacteria detection method and reagent |
CN105087576A (en) * | 2015-09-29 | 2015-11-25 | 西南民族大学 | Detection kit for Yersinia rohdei causing enterocolitis and detection method |
EP3243907A1 (en) * | 2016-05-13 | 2017-11-15 | Curetis GmbH | Stable pan-genomes and their use |
CN106434890B (en) * | 2016-08-30 | 2020-02-21 | 上海生物信息技术研究中心 | Method, primer and kit for rapidly detecting yersinia enterocolitica at constant temperature |
WO2020159977A1 (en) * | 2019-01-29 | 2020-08-06 | The Translational Genomics Research Institute | Methods and assays for detection and subtyping of microbial pathogens |
US20220042078A1 (en) * | 2019-04-29 | 2022-02-10 | Illumina, Inc. | Identification and analysis of microbial samples by rapid incubation and nucleic acid enrichment |
CN110923349B (en) * | 2019-12-30 | 2022-12-06 | 广东省科学院微生物研究所(广东省微生物分析检测中心) | Species-specific detection molecular tags 3283 and 3316 of yersinia enterocolitica and rapid detection method thereof |
-
2020
- 2020-12-30 CN CN202011615514.XA patent/CN112795669B/en active Active
-
2021
- 2021-04-13 WO PCT/CN2021/087078 patent/WO2022141943A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2022141943A1 (en) | 2022-07-07 |
CN112795669A (en) | 2021-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2596059C (en) | Method of quantitatively analysing microorganism targeting rrna | |
WO2022141934A1 (en) | Staphylococcus aureus standard strains containing specific molecular target, and detection and use thereof | |
Hongping et al. | Insufficiency of the Kanagawa hemolytic test for detecting pathogenic Vibrio parahaemolyticus in Shanghai, China | |
CN111621451B (en) | Bacillus, method for detecting antibiotic residue by using bacillus and application of method | |
CN112795669B (en) | Yersinia enterocolitica standard strain containing specific molecular target and detection and application thereof | |
Jamshidi et al. | Isolation and identification of Campylobacter spp. and Campylobacter coli from poultry carcasses by conventional culture method and multiplex PCR in Mashhad, Iran | |
CN112877448B (en) | Bacillus cereus standard strain containing specific molecular target and detection and application thereof | |
WO2022141939A1 (en) | Vibrio parahaemolyticus standard strains containing specific molecular target, and detection and use thereof | |
CN112575100B (en) | Staphylococcus albus standard reference strain containing specific molecular target and detection and application thereof | |
CN115873930A (en) | Double-target-point drug-resistant salmonella detection method based on RPA-Cas12a | |
CN112899378B (en) | Cronobacter sakazakii standard strain containing specific molecular target and detection and application thereof | |
CN114262751A (en) | Novel coronavirus nucleic acid detection kit and preparation method thereof | |
CN103333961A (en) | Primer, probe and method for detecting gardnerella vaginalis and kit | |
CN112646906B (en) | Diarrhea-causing escherichia coli standard reference strain containing specific molecular target and detection and application thereof | |
CN112899379B (en) | Campylobacter jejuni standard strain containing specific molecular target and detection and application thereof | |
CN113388539B (en) | Salmonella standard strain containing specific molecular target and detection and application thereof | |
CN112725474B (en) | Listeria monocytogenes standard strain containing specific molecular target and detection and application thereof | |
CN108251496B (en) | Microorganism mass spectrum detection capability verification article and preparation method thereof | |
CN113355330B (en) | ssDNA aptamer for specifically recognizing Weissella viridescens and screening method and application thereof | |
CN110499374B (en) | Triple PCR primer group for detecting Klebsiella pneumoniae, kit and application | |
Aktayeva et al. | Isolation, identification and use of strains of bacteria of the genus Bacillus in a microbiological test for the determination of antibiotics in milk | |
Zhang et al. | The value and application of different assays in carbapenemase detection | |
Al-Nour et al. | Molecular phylogenetic study on Pseudomonas stutzeri isolated from currency notes in Khartoum State, Sudan and identified via 16S rRNA gene sequence analysis | |
CN115725758A (en) | Burkholderia gladioli containing specific molecular target, coconut toxin pathogenic standard strain of Burkholderia gladioli, detection method and application of coconut toxin pathogenic standard strain | |
Deng et al. | Wenqu Zhou1, Kan Wang2, Wei Hong1, Caiying Bai3, Ling Chen4, 5, Xin Fu1*, Tengyi Huang6 and Junyan Liu7 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |